ClinicalTrials.Veeva

Menu

Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome (T-RIS)

C

Centre Hospitalier Universitaire de Nīmes

Status

Completed

Conditions

Multiple Sclerosis
Radiologically Isolated Syndrome

Treatments

Other: Analysis of cerebrospinal fluid and serum

Study type

Observational

Funder types

Other

Identifiers

NCT03357887
NIMAO/2016/ET-01

Details and patient eligibility

About

To look at the prognostic value of new biomarkers in CSF and serum for characterisation of multiple sclerosis

Enrollment

100 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • Patients have given their free consent for use of their samples in research
  • Patients have at least 2 years of clinical and radiological follow-up data available Exclusion criterion
  • No follow-up of patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems